pharmaceutical compliance congress
pharmaceutical compliance congress
pharmaceutical compliance congress
pharmaceutical compliance congress
pharmaceutical compliance congress
pharmaceutical compliance congress



Overview | Agenda | Continuing Education | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Speaking Proposals | Administration | Webcast Log In | Past Conferences | Contact Us | Home






Sponsored by
The Pharmaceutical
Compliance Forum


SIXTEENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS


Transformational Learning - Effective Knowledge Exchange

October 21 - 23, 2015
Mandarin Oriental
Washington, DC


KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, Food and Drug Administration, Silver Spring, MD

Robert Barrington, PhD
Executive Director, Transparency International-UK, London, UK

Douglas Brown
Deputy Director, Data Sharing & Partnership Group, Center for Program Integrity, Centers for Medicare and Medicaid Services, US Department of Health and Human Services, Baltimore, MD

Benjamin C. Mizer, Esq.
Principal Deputy Assistant Attorney General, Civil Division, Former Counselor to Attorney General Eric H. Holder, Jr., US Department of Justice, Washington, DC

Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

Jeffrey S. Sallet
National Chief of Public Corruption and Civil Rights, Federal Bureau of Investigation, Washington, DC

FEATURING A COMPLIANCE OFFICER ROUNDTABLE

Melissa S. Barnes, Esq.
Chief Ethics and Compliance Officer, Lilly, Indianapolis, IN

Tricia Glover
Vice President, US Chief Compliance Officer, Teva Pharmaceuticals, Kansas City, MO

Jonathon L. Kellerman
Executive Vice President, Global Chief Compliance Officer, Actavis-Allergan, New York, NY

Lawrence P. Platkin
Vice President and Compliance Officer, Bayer HealthCare LLC, Whippany, NY

Trudy Tan
Vice President Compliance North America, AstraZeneca, Wilmington, DE

Erinn Hutchinson
Partner, PwC, Philadelphia, PA (Moderator)

A QUI TAM ROUNDTABLE

Jillian Estes, Esq.
Partner, James Hoyer Newcomer & Smiljanich, PA, Former Case Assistant, International Division, National Center for Missing and Exploited Children, Tampa, FL

Loren Jacobson, Esq.
Partner, Waters & Kraus LLP, Dallas, TX

Joseph Trautwein, Esq.
Joseph Trautwein & Associates LLC, Former Assistant US Attorney, Eastern District of Pennsylvania, Philadelphia, PA

Jonathan L. Diesenhaus, Esq.
Partner, Hogan Lovells LLP, Former Senior Trial Attorney, Civil Fraud Section, US Department of Justice, Philadelphia, PA (Moderator)

AN AUSA ROUNDTABLE

Colin M. Cherico
Assistant US Attorney, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA

K. Nathaniel Yeager, Esq.
Chief, Health Care Fraud Unit, United States Attorney's Office, District of Massachusetts, Boston, MA

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC (Moderator)

FCPA HYPOTHETICAL CASE STUDY

Jeffrey H. Knox, Esq.
Partner, Simpson Thacher, Former Chief, Fraud Section, Criminal Division, Former Assistant U.S. Attorney, Eastern District of New York, US Department of Justice, Washington, DC

Cheryl J. Scarboro, Esq.
Partner, Simpson Thacher, Former first Chief, FCPA Unit, US Securities and Exchange Commission, Washington, DC

Ashley Watson, Esq.
Senior Vice President, Chief Ethics & Compliance Officer, Merck, Inc., Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY (Moderator)

PRECONFERENCE SESSIONS
  • Preconference I: Regulatory Concepts: Basic Principles
  • Preconference II: Innovations in Risk Assessment, Auditing and Monitoring
  • Preconference III: Advanced Issues in Domestic and Global Transparency and Analytics: Taking the Data to the Next Level
  • Preconference IV: Advanced Global Compliance Issues
PLENARY SESSIONS
  • Keynote: OIG Update
  • AUSA Panel
  • Keynote: FBI's New Focus on FCPA Investigations
  • Keynote: FDA-OPDP Update
  • Chief Compliance Officer Panel: Now that the CIA is Completed, How is the Ethics and Compliance Program Evolving?
  • FCPA Anticorruption Panel: Examining a Hypothetical Case from All Sides: DOJ, SEC, and CCO
  • Keynote: US DOJ Civil Section Update
  • Keynote: Transparency International's New Pharma Industry Initiative
  • Qui Tam Panel
  • Keynote: Recent Developments in the Debate over Off-Label Communications and the First Amendment
  • Keynote: Update from CMS on Open Payments
  • Consolidation, Vertical Integration and Cross-Border Business: Confronting "Next Generation" Compliance Priorities Panel
  • Millennials and the Future of Ethics and Compliance Programs: New Technologies and Eternal Issues
HALF-DAY CLOSED SESSION
  • INDUSTRY-ONLY COMPLIANCE BEST PRACTICES THINK TANK

    Including an Update from PhRMA

    (Industry-only session for pharmaceutical company compliance professionals and in-house counsel only)
PHARMA CONGRESS IS

MINI SUMMITS
  • Mini Summit I: Managing Speaker Program Compliance: Benchmarking and Best Practices
  • Mini Summit II: R&D Compliance: Prepare Now for Future Enforcement
  • Mini Summit III: Business Development Part 1: Mergers and Acquisitions- Preparing to be Acquired and Pre-Deal Due Diligence
  • Mini Summit IV: Evaluating Compliance Program Effectiveness: Board Responsibilities, Board Advisors and Compliance Experts
  • Mini Summit V: Payers and Providers Part 1-Evolving Healthcare Systems and Promotional Interactions
  • Mini Summit VI: Patient Support Programs Part 1-Getting Closer to the Patient
  • Mini Summit VII: Predictive Analytics
  • Mini Summit VIII: Coordinating Risk Management across Control Functions- Audit, Compliance, Finance, Legal, Regulatory and Quality - An Opportunity to Leverage Technology
  • Mini Summit IX: Managing Multi-National HCP Meetings -Complying with the Codes and Transparency Requirements
  • Mini Summit X: Business Development Part 2: Mergers and Acquisitions -Post-Deal Due Diligence and Integration Challenges
  • Mini Summit XI: Impact of Public Disclosures on Operations and Processes in Life Science Organizations
  • Mini Summit XII: Patient Support Programs Part 2: Patient Services -Privacy and Pharmacovigilance Considerations
  • Mini Summit XIII: Innovation in Training and Communications
  • Mini Summit XIV: Compliance Considerations when Evaluating Non-Traditional HCP Compensation Arrangements: Royalties, Stock Options and Licensing Agreements
  • Mini Summit XV: New Product Launches and the Pre-Launch Period: Strengthening the Partnership with the Business
  • Mini Summit XVI: Business Development Part 3: Joint Ventures and Co-Promotion Arrangements
  • Mini Summit XVII: Marketing and Medical Affairs: Where is the Line in the Sand?
  • Mini Summit XVIII: Structuring Specialty Pharmacy Distribution Arrangements in a Turbulent Regulatory Environment
  • Mini Summit XIX: Payers and Providers Part 2: Value Propositions in Contractual Relationships: Real World Evidence, Outcomes Research, and Comparative Effectiveness

FEATURED FACULTY

Lori Alarimo, Esq.
Director, Healthcare & Life Sciences Disputes, Regulatory, Compliance & Investigations, Navigant Consulting, Inc., Irvine, CA

Corey R. Amundson, Esq.
First Assistant United States Attorney and Chief, Criminal Division, United States Attorney's Office, Middle District of Louisiana, Baton Rouge, LA

Jeff Antoon
Director Internal Audit, Johnson & Johnson, New Brunswick, NJ

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL

Yogesh Bahl, CPA, MBA
Managing Director, AlixPartners, New York, NY

Dennis K. Barnes, MBA, JD, CPA
Vice President, Chief Compliance Officer, PAREXEL International, Waltham, MA

Gregory Beeman
Lilly USA Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN

Thomas Beimers, Esq.
Healthcare, Compliance, and Government Investigations Attorney at Faegre Baker Daniels LLP, Minneapolis, Minnesota

Ann S. Brandt, PhD
Partner, HealthCare Appraisers, Inc., Delray Beach, FL

Katherine Buckley, MBA
Principal, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA

William Buzzeo, MS
General Manager, US Compliance Business at IMS Health, Plymouth Meeting, PA

Chris Castro, CCEP
Associate Director, Healthcare & Life Sciences Disputes, Regulatory, Compliance & Investigations, Navigant Consulting, Inc., Phoenix, AZ

Regina Gore Cavaliere, Esq.
Principal, Advisory, KPMG, Former Vice President & Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Short Hills, NJ

Colin M. Cherico
Assistant US Attorney, United States Attorney's Office, Eastern District of Pennsylvania, Philadelphia, PA

Kerry Clem
Senior Vice President, Sales, Acorda Therapeutics, Ardsley, NY

Chris Cobourn
Managing Director, Huron Consulting Group, New York, NY

Kellie Branson Combs, Esq.
Counsel, Ropes and Gray, Washington, DC

Joseph Coniker, GMP
Principal, National Practice Leader, Business Analytics, Grant Thornton, Philadelphia, PA

John Conrad
Principal, Deloitte, Philadelphia, PA

Thomas E. Costa, Esq.
Compliance Consultant, Former Vice President, US Pharmaceuticals Compliance, Bristol-Myers Squibb, Yardley, PA

Traci Coughlan, Esq.
Principal, Advisory Services, The Red Flag Group, Berlin, MD

Kris Curry, MBA
Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Former Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson, Philadelphia, PA

Paul Curtin, JD, CFE
Compliance Officer - Global Research and Development, Actavis, Former Head of Compliance - Ex-US, Forest Laboratories, New York, NY

BJ D'Avella, MBA
Senior Director, Huron Consulting Group, New York, NY

Sujata Dayal, Esq.
Vice President Health Care Compliance and Privacy, Pharmaceuticals, Johnson & Johnson; Former Global Chief Compliance Officer and Corporate Vice President, Biomet, Inc., Former Member PCF Executive Committee, Chicago, IL

Mark DeWyngaert, MBA, PhD
Managing Director, Huron Consulting Group, New York, NY

Justin Dillon
Senior Director - Compliance, Auditing & Monitoring, Incyte, Wilmington, DE

Daniel L. Dovdavany, Esq.
Assistant General Counsel North America Litigation & Investigations, Sanofi US, Bridgewater, NJ

Jayson Dukes
Senior Managing Director, FTI, New York, NY

Corey Dunbar, CFE
Senior Manager, Fraud Investigations & Dispute Services, Ernst & Young LLP, New York, NY

Michael B. Dusseau
Vice President, Compliance Operations, Allergan PLC, Former Vice President, Compliance, Bayer, Parsippany, NJ

Nathaniel B. Edmonds, Esq.
Partner, Paul Hastings, Former Assistant Chief, Foreign Corrupt Practices Act Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Marc Eigner, MBA, MS
Senior Partner and Co-Founder, Polaris, New York, NY

Margaret K. Feltz, MA, JD
Executive Director, Corporate Compliance, Purdue Pharma LP, Former Member, PCF Executive Committee, Stamford, CT

Alison Fethke, Esq.
Counsel, Health Care Group, Ropes & Gray, Chicago, IL

Esther M. Flesch, Esq.
Partner, Trench, Rossi e Watanabe, A Baker McKenzie Affiliate, São Paulo, Brazil

Christopher Fletchall, MBA
Senior Director, Ethics and Compliance, Eli Lilly and Company, Indianapolis, IN

Jeff Francer, Esq.
Vice President and Senior Counsel, PhRMA, Former Associate Chief Counsel, Food and Drug Administration, Washington, DC

Ronni E. Fuchs, Esq.
Partner, Pepper Hamilton LLP, Princeton, NJ

James Gibney
Senior Director of Compliance, Regeneron Pharmaceuticals, Former Director, Worldwide Programs and US Investigations - Corporate Compliance, Pfizer, Tarrytown, NY

Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells LLP, Former Executive Assistant U.S. Attorney, Eastern District of Pennsylvania, Philadelphia, PA

Thomas M. Glavin
Vice President, Head of Compliance - US, Shire, Wayne, PA

Edward Glynn, MBA
Principal, Ernst & Young LLP, New York, NY

William Greenrose, MA, MBA
Director, Advisory - Governance Regulatory and Risk Strategies Practice, Deloitte & Touche, LLC, Boston, MA

Tali Guy, Esq.
Senior Director, Global R&D Compliance Officer, Teva Pharmaceutical Industries Ltd., Petah Tikva, Israel



Kathleen Hamill
Assistant General Counsel, Johnson & Johnson, Philadelphia, PA

Samantha Hand
Global Training Manager, Johnson & Johnson, Titusville, NJ

Jeffrey L. Handwerker, Esq.
Partner, Arnold & Porter, Washington, DC

Samir Hans, MS
Principal at Deloitte, Washington, DC

Alessandra Hawthorne, Esq.
Vice President, Chief Ethics and Compliance Officer, Boehringer-Ingeheim Pharmaceuticals, Ridgefield, CT

Wendy Heckelman, PhD
President, WLH Consulting, Inc., Fort Lauderdale, FL

Saul Helman, MD, MBA
Managing Director and Life Sciences Practice Leader, Navigant Consulting, Inc., Indianapolis, IN

William I. Intner, Esq.
Partner, Hogan Lovells LLP, Baltimore, MD

Mark A. Jensen, Esq.
Partner, Special Matters and Government Investigations Team, King & Spalding, Washington, DC

Michael Joachim, Esq.
Head of Global Corporate Compliance, Genzyme, Cambridge, MA

Paul E. Kalb, JD, MD
Partner and Global Coordinator, Life Sciences Practice, Sidley Austin LLP, Washington, DC

Gary Keilty
Managing Director, FTI, Washington, DC

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC

Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC

Joanne Lahner, Esq.
Vice President, GHH Compliance at Merck, North Wales, PA

Stephen M. Lawniczak, Esq.
Senior Counsel, AbbVie, Chicago, IL

Terri Ledva, MS
Senior Manager Compliance, Iroko Pharmaceuticals LLC, Philadelphia, PA

Natasha Leskovsek, RN, MPM, MBA, JD
Health Care & Life Sciences Regulatory Practice, Cooley, LLP, Washington DC

John "Jack" S. Linehan, Esq.
Associate, Epstein Becker Green, Former Special Assistant US Attorney, US Attorney's Office for the District of Maryland, Washington, DC

Mark Linver, MS
Managing Director, Huron Consulting Group, New York, NY

Kari Loeser, Esq.
Senior Counsel, Jazz Pharmaceuticals, Palo Alto, CA

Phillip Lo Scalzo, Esq.
Senior Vice President, Chief Compliance Officer, BioMarin Pharmaceutical Inc., Novato, CA

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP; Former Acting United States Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC

David J. Ludlow, Esq.
Partner, Sidley Austin, Washington, DC

Maureen McGirr, Esq.
Vice President, Office of Ethics, Global Compliance Organization, Merck & Co., Inc., Kenilworth, NJ

Gary Mendelsohn
Assistant Director, Corporate Compliance For Oncology, Astellas, Greer, SC

Megan Mikkelsen, CIPP/US, CHPS
Director, US Chief Privacy Officer, Teva Pharmaceuticals, Kansas City, MO

Véronique Monjardet, PhD
Country Manager - France, Polaris, Paris, France

Ned Mumtaz, MBA, MIS
Practice Leader and Associate Partner, Streebo Inc., Princeton, NJ

Stuart A. Neiberg, MAcc, CPA, CFA
Director, HealthCare Appraisers, Delray Beach, FL

George K. Ng, Esq.
Executive Vice President & Chief Legal Officer, Sorrento Therapeutics, Inc., San Diego, CA

Michael O'Connor, MS
Senior Director, Compliance and Ethics, Alexion Pharmaceuticals, Inc., Cheshire, CT

John Patrick Oroho, Esq.
Executive Vice President & Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio Bromberg & Newman, PC, Morristown, NJ

Gus Papandrikos, MBA
Senior Director, Compliance, Daiichi Sankyo, Parsippany, NJ

Amy Pawloski, CPA, CCEP
Head of US Compliance & Ethics Monitoring and Data Analytics, Bristol-Myers Squibb, Plainsboro, NJ

Jeremy Perisho
Partner and US FAS Leader, Life Sciences & Health Care, Deloitte Financial Advisory Services LLP, Boston, MA

Kathleen Peterson, Esq.
Special Counsel, Cooley LLP, Washington, DC

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Legal Counsel, Ad Hoc Sunshine and State Law Compliance Group, Washington, DC

Terra L. Reynolds, Esq.
Of Counsel, Litigation Department, Paul Hastings LLP, Assistant U.S. Attorney, Northern District of Illinois, Chicago, IL

Brian Riewerts, MPA
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK

Janet L. "Lucy" Rose, MBA
President, Lucy Rose and Associates, LLC, Former Director, DDMAC, FDA, Washington, DC

Lee H. Rosebush, JD, PharmD, MS, MBA
Pharmacy Team Leader and FDA Partner, Baker &Hostetler LLP, Washington DC

Jeffrey Rosenbaum, MBA
SVP, Chief Compliance and Risk Officer, Shire, Former Chief Compliance Officer, Vertex Pharmaceuticals, Lexington, MA

Lauren K. Roth, Esq.
Assistant General Counsel, PhRMA, Washington, DC

Barbara Rowland, Esq.
Principal, Internal Investigations and White Collar Defense Group, Post & Schell, PC, Washington, DC

Matthew Ruble, MS
Senior Manager, Grant Thornton, Philadelphia, PA

John D. Shakow, Esq.
Partner, FDA& Life Sciences Practice, King & Spalding, Washington, DC

Paul Silver
Practice Leader and Managing Director, Huron Consulting Group, Atlanta, GA

Scot Steinheiser, CHC, CCEP
Managing Partner and Founder, Commercial Compliance Consulting, SCS Compliance Group LLC, Mundelein, IL

Terrell Sweat, MBA
Compliance Director, Actelion Pharmaceuticals, South San Francisco, CA

Jack T. Tanselle, MBA
Managing Director, Healthcare Dispute, Compliance and Investigation Practice, Navigant Consulting, Inc., Indianapolis, IN

Yuet Ming Tham, Esq.
Partner, Sidley Austin LLP, Former, Asia-Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Hong Kong

Fernando Villegas, MS
Director, Oncology Marketing, Jazz Pharmaceuticals, Palo Alto, CA

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Former R&D Compliance Officer, GlaxoSmithKline, West Chester, PA

Jonathan Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA

Stephanie Wisdo, Esq.
Corporate Attorney, Otsuka America Pharmaceutical, Inc., Princeton, NJ

Raymond S. Wysmierski, MBA, MJP
Associate Director, Compliance, Avanir Pharmaceuticals, Inc, Aliso Viejo, CA

2015 GLOBAL PHARMA COMPLIANCE CONGRESSES

FIFTH ASIA PACIFIC PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
Offered in Sequence with the APEC 2nd Business Ethics for Small & Medium Size Enterprises (SME) Forum (August 19 - 20, 2015)
August 17 - 18, 2015
Sofitel Philippine Plaza
Manila, Philippines
www.AsianPharmaCongress.com

OTHER GLOBAL PHARMA CONGRESS CITIES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul

2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid

2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Shanghai


2015 - Manila



EARLY BIRD REGISTRATION DISCOUNT
SAVE UP TO $400 -
Register by September 4, 2015 for Early Bird discount. Save up to $400.
Click here to register.

BROCHURE NOW AVAILABLE
Click here to download.
SPONSORED BY:

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.

CO CHAIRS

Matthew D'Ambrosio, MBA, JD
Senior Vice President, Chief Compliance and Ethics Officer, Sunovion Pharmaceuticals Inc., Marlborough, MA

Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb Company, Plainsboro, NJ

Elizabeth Jobes
Legal Counsel and Head of Corporate Compliance, Spark Therapeutics, Philadelphia, PA
INVITATION TO ATTEND THE PCF PHARMA CONGRESS

As the new Vice President, Pharma and Medical Device Content,Let u Global Health Care - Life Sciences, LLC, it is my pleasure to invite you to attend the 2015 Sixteenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum sponsored by the PCF. This year's Congress will feature presentations by leading government regulators, company compliance professionals, in-house counsel, prominent industry consultants and legal counsel. Please plan to join me and the Planning Committee for three stimulating days of continuing education, networking and best practice sharing.


Kelly B. Freeman, PhD
Vice President, Pharma and Medical Device Content, Global Health Care - Life Sciences, LLC, Former Senior Advisor, Ethics and Compliance, Eli Lilly and Company, Former Member, PCF Executive Committee, Indianapolis, IN
MEDIA PARTNERS:






GRANTORS:
GOLD


SILVER








BRONZE
































CONTINUING EDUCATION CREDITS:
Accounting Professionals: Approved for up to 17.5 NASBE CPE credits.

Compliance Professionals: The Congress is currently pending approval to offer Compliance Certification Board CCB Credits.

Attorneys: The Congress is currently pending approval to offer California, Pennsylvania and Texas MCLE Credit.

Click here for more information.

2015 PCF PHARMA CONGRESS PLANNING COMMITTEE
Matthew D'Ambrosio, JD, MBA
Senior Vice President, Chief Compliance and Ethics Officer, Sunovion Pharmaceuticals, Inc., Marlborough, MA (Co-chair)

Gary DelVecchio
Executive Director, US Pharmaceutical Compliance and Ethics, Bristol-Myers Squibb, Plainsboro, NJ (Co-chair)

Elizabeth V. Jobes, Esq.
Head of Corporate Compliance and Legal Counsel, Spark Therapeutics, Philadelphia, PA (Co-chair)

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma plc, Chicago, IL

Scott Bass, Esq.
Partner and Head, Global Life Sciences Team, Sidley Austin LLP, Washington, DC

John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Washington, DC

Yogesh Bahl, MBA
Managing Director, AlixPartners, New York, NY

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY

Mary Bradley, PharmD
Healthcare Compliance Officer, Johnson & Johnson, Philadelphia, PA

Eve Costopoulos, Esq.
Former Vice President and Chief Ethics and Compliance Officer, Eisai Inc., Woodcliff Lake, NJ

Kris Curry, MBA
Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Philadelphia, PA

Clive Davis, MA, JD
Vice President, Chief Compliance Officer , UCB Pharma, Atlanta, GA

Michael B. Dusseau
Vice President, Compliance Operations, Actavis, Inc., Parsippany, NJ

Margaret K. Feltz, MA, JD
Executive Director, Corporate Compliance, Purdue Pharma LP, Stamford, CT

Alison Fethke, Esq.
Counsel, Health Care Group, Ropes & Gray, Chicago, IL

Jeffrey Fleming, Esq.
Vice President Compliance North America and US Compliance Officer, AstraZeneca Pharmaceuticals LP, Wilmington, DE

Thomas M. Glavin
Vice President, Head of Compliance - US, Shire, Wayne, PA

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, New York, NY

Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells LLP, Philadelphia, PA

Wendy C. Goldstein, Esq.
Partner, Health Care & Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Steven Guymon
Senior Compliance Advisor, Eli Lilly and Company, Indianapolis, IN

Alessandra Hawthorne, Esq.
Vice President, Chief Ethics and Compliance Officer, Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT

Wendy Heckelman, PhD
President and Founder, WLH Consulting, Inc., Fort Lauderdale, FL

Erinn Hutchinson
Partner, Advisory Services, PricewaterhouseCoopers, Philadelphia, PA

Margaret Jackson
National Industry Marketing Director, Grant Thornton LLP, Raleigh, NC

Michael Joachim, Esq.
Head of Global Corporate Compliance, Genzyme, a Sanofi Company, Cambridge, MA

Jeffrey S. Klimaski, MBA, CPA
Vice President, Global Ethics and Compliance Officer, BTG International Inc., Philadelphia, PA

Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC

Terri Ledva, MS
Ethics & Compliance Leader, Iroko Pharmaceuticals, Philadelphia, PA

Beth Levine, Esq.
Vice President, Associate General Counsel, Chief Compliance Officer, Regeneron, New York, NY

Christine Longawa, MA, CPA, CFE
Life Sciences Disputes, Compliance & Investigations Associate Director, Navigant Consulting, Chicago, IL

Maureen McGirr, Esq.
Vice President Office of Ethics, Global Compliance Organization , Merck, Philadelphia, PA

Maxine Nogard
Compliance Director, Biogen Idec, Weston, MA

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

Jeremy Perisho
Partner and US FAS Leader, Life Sciences & Health Care, Deloitte Financial Advisory Services LLP, Boston, MA

Lori Queisser
Senior Vice President and Global Chief Compliance Officer, Teva Pharmaceuticals, Horsham, PA

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC

Jeffrey Rosenbaum, MBA
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Cambridge, MA

Michael Shaw, Esq.
Vice President and Compliance Officer, North America Pharmaceuticals & Global Franchises, GlaxoSmithKline, Philadelphia, PA

Glenna Shen, Esq.
Head of Compliance, Onyx Pharmaceuticals, South San Francisco, CA

Paul Silver
Practice Leader and Managing Director, Huron Consulting Group, Atlanta, GA

David Vance, Esq.
Senior Director Business Conduct, Noven Pharmaceuticals, Inc., Miami, FL

Seth B. Whitelaw, JD, PhD
President & Chief Executive Officer, Whitelaw Compliance Group, LLC, West Chester, PA

Raymond Wysmierski, MBA, MJP
Associate Director, Compliance, Avanir Pharmaceuticals, Aliso Viejo, CA

FOLLOW PHARMA CONGRESS ON




PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction


LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office





WEBCAST INTERFACE SAMPLE

Click here for a sample stream




This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.








THE 2014 FIFTEENTH ANNUAL PHARMA CONGRESS CONTENT IS NOW AVAILABLE IN VARIOUS POST CONFERENCE FORMATS

The 2014 Fifteenth Annual Pharma Congress conference content is now available in a variety of formats.

You may purchase the Congress streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE PHARMA CONGRESS CONTENT AS FOLLOWS:


Online Archive of 2014 Fifteenth Annual Pharma Congress Presentations today!
$595

Order Now


Flash Drive of 2014 Fifteenth Annual Pharma Congress Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE PHARMA CONGRESS INDIVIDUAL PRESENTATIONS:

Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).







Overview | Agenda | Continuing Education | Promotional Opportunities | Grantors & Exhibitors | Travel/Hotel
Registration | Speaking Proposals | Administration | Webcast Log In | Past Conferences | Contact Us | Home




© Health Care Conference Administrators
Contact Webmaster